Opendata, web and dolomites

CholangioConcept SIGNED

Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CholangioConcept project word cloud

Explore the words cloud of the CholangioConcept project. It provides you a very rough idea of what is the project "CholangioConcept" about.

screening    therapies    becomes    urgently    cancer    metabolism    altered    resection    icc    drugs    hepatocytes    complexity    liver    driving    chimaeric    tumors    regimen    envision    emerged    strategies    identification    inevitably    surgical    therapy    discussed    ing    sharply    hallmarks    gut    option    influences    kras    expertises    intrahepatic    irresectable    cytotoxic    yield    frequent    oncogenomic    cholangiocarcinogenesis    bile    mouse    vivo    aggressive    unclear    models    microbiome    dissect    mosaic    profiling    progression    curative    vulnerabilities    clear    heterogeneity    translational    lifestyle    therapeutic    western    stable    functionally    direct    treatment    molecular    tumor    metastasis    functional    metastatic    solid    characterization    harbor    hepatic    genetic    incidence    exists    systemic    develops    time    adult    health    innovative    rates    data    employ    mechanisms    primary    ccc    resistance    poorly    shrna    insights    duct    advantage    erc    emphasis    cholangiocarcinoma    diagnosis   

Project "CholangioConcept" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙998˙898 €
 EC max contribution 1˙998˙898 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-CoG
 Funding Scheme ERC-COG
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 1˙998˙898.00

Map

 Project objective

Genetic heterogeneity and complexity are hallmarks of metastatic solid tumors and therapy resistance inevitably develops upon treatment with cytotoxic drugs or molecular targeted therapies. Cholangiocarcinoma (CCC, or bile duct cancer) represents the second most frequent primary liver tumor and has emerged as a health problem with sharply increasing incidence rates, in particular of intrahepatic CCC (ICC). The reason for increased CCC incidence remains unclear, but influences of western lifestyle and a resulting altered hepatic metabolism have been discussed. Surgical resection represents the only curative option for the treatment of CCC, however, many tumors are irresectable at the time of diagnosis. CCC represents a highly aggressive and metastatic tumor type and currently no effective systemic therapy regimen exists. The overall molecular mechanisms driving CCC formation and progression remain poorly characterized and it thus becomes clear that a detailed molecular characterization of cholangiocarcinogenesis and the identification of robust therapeutic targets for CCC treatment are urgently needed. Taking advantage of our strong expertises in chimaeric (mosaic) liver cancer mouse models and stable in vivo shRNA technology, we here propose a comprehensive and innovative approach to i) dissect molecular mechanisms of cholangiocarcinogenesis, with a particular emphasis on Kras driven ICC development from adult hepatocytes and oncogenomic profiling of ICC metastasis, ii) to employ direct in vivo shRNA screening to functionally identify new therapeutic targets for CCC treatment and iii) to characterize the role of the gut microbiome for CCC progression and metastasis. We envision this ERC-funded project will yield important new insights into the molecular mechanisms of CCC development, progression and metastasis. As our work comprises direct and functional strategies to identify new vulnerabilities in CCC, the obtained data harbor a very high translational potential.

 Publications

year authors and title journal last update
List of publications.
2018 Marco Seehawer, Florian Heinzmann, Luana D’Artista, Jule Harbig, Pierre-François Roux, Lisa Hoenicke, Hien Dang, Sabrina Klotz, Lucas Robinson, Grégory Doré, Nir Rozenblum, Tae-Won Kang, Rishabh Chawla, Thorsten Buch, Mihael Vucur, Mareike Roth, Johannes Zuber, Tom Luedde, Bence Sipos, Thomas Longerich, Mathias Heikenwälder, Xin Wei Wang, Oliver Bischof, Lars Zender
Necroptosis microenvironment directs lineage commitment in liver cancer
published pages: 69-75, ISSN: 0028-0836, DOI: 10.1038/s41586-018-0519-y
Nature 562/7725 2019-04-18
2018 Laura Faletti, Lukas Peintner, Simon Neumann, Sandra Sandler, Thomas Grabinger, Sabine Mac Nelly, Irmgard Merfort, Chun-Hao Huang, Darjus Tschaharganeh, Tae-Won Kang, Florian Heinzmann, Luana D’Artista, Ulrich Maurer, Thomas Brunner, Scott Lowe, Lars Zender, Christoph Borner
TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation
published pages: n/a, ISSN: 2041-4889, DOI: 10.1038/s41419-018-0935-9
Cell Death & Disease 9/9 2019-04-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CHOLANGIOCONCEPT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CHOLANGIOCONCEPT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More